|
|
|
|
For the years ended |
|
|||||||
|
|
Deferred tax assets |
|
2017 |
|
2016 |
|
2015 |
|
|||
|
|
Investment tax credits |
|
$ |
3,108,576 |
|
$ |
2,689,744 |
|
$ |
3,454,503 |
|
|
|
Capital assets |
|
|
500,445 |
|
|
328,039 |
|
|
212,311 |
|
|
|
Share issue expenses |
|
|
1,774,820 |
|
|
772,687 |
|
|
999,066 |
|
|
|
Non-capital loss carry forwards |
|
|
56,627,473 |
|
|
22,828,376 |
|
|
15,639,367 |
|
|
|
Foreign exchange |
|
|
5,500 |
|
|
(12,388 |
) |
|
1,093 |
|
|
|
Research and development expenditures |
|
|
265,260 |
|
|
68,037 |
|
|
3,523,925 |
|
|
|
Reserve for legal damages |
|
|
— |
|
|
28,205,068 |
|
|
— |
|
|
|
Deferred compensation |
|
|
31,387 |
|
|
50,454 |
|
|
29,907 |
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
$ |
62,313,461 |
|
$ |
54,930,017 |
|
$ |
23,860,172 |
|
|
|
|
|
|
|
|
|
|
|
|||